4527 — Rohto Pharmaceutical Co Cashflow Statement

0.000.00%

Last trade - 00:00

HealthcareBalancedLarge CapNeutral

Annual cashflow statement for Rohto Pharmaceutical Co, fiscal year end - March 31st, JPY millions except per share, conversion factor applied.

	2020 March 31st	2021 March 31st	2022 March 31st	2023 March 31st	2024 March 31st
Period Length:	12 M	12 M	12 M	12 M	12 M
Source:	Yuho	Yuho	Yuho	Yuho	Yuho
Standards:	JAS	JAS	JAS	JAS	JAS
Status:	Final	Final	Final	Final	Final
Net Income/Starting Line	21,730	23,006	27,953	34,290	41,518
Depreciation
Amortisation
Non-Cash Items	924	561	1,792	1,112	-563
Unusual Items
Equity in Net Earnings/Losses
Other Non-Cash Items
Changes in Working Capital	-10,482	-10,238	-10,167	-12,278	-15,374
Change in Accounts Receivable
Change in Inventories
Change in Accounts Payable
Change in Other Liabilities
Other Operating Cash Flow
Cash from Operating Activities	19,109	20,077	27,251	30,925	34,268
Capital Expenditures	-6,433	-10,304	-11,328	-9,908	-8,912
Purchase of Fixed Assets
Purchase / Acquisition of Intangibles
Other Investing Cash Flow Items	-2,972	67	-5,078	-3,268	-7,405
Acquisition of Business
Sale of Fixed Assets
Sale/Maturity of Investment
Purchase of Investments
Other Investing Cash Flow
Cash from Investing Activities	-9,405	-10,237	-16,406	-13,176	-16,317
Financing Cash Flow Items	-194	-216	-698	-1,641	-7,086
Other Financing Cash Flow
Total Cash Dividends Paid
Net Issuance / Retirement of Debt
Cash from Financing Activities	-1,603	-2,347	3,470	-16,199	-13,784
Foreign Exchange Effects
Beginning Cash Balance
Ending Cash Balance
Net Change in Cash	7,320	7,589	18,650	6,786	8,870